Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejo Rodriguez-Vida

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Expert Review of Anticancer Therapy|March 16, 2018
Avelumab for the treatment of urothelial cancerAlejo Rodriguez-Vida, Joaquim Bellmunt
JAMA Oncology|April 12, 2019
Treatment of Metastatic Urothelial Cancer in 2018Joaquim Bellmunt, Alejo Rodriguez-Vida
ESMO Open|November 16, 2016
Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinomaAlejo Rodriguez-Vida, Michiel Strijbos, Thomas Hutson
BJU International|February 18, 2014
Mammalian target of rapamycin (mTOR)-related non-infectious pneumonitis: a potential biomarker of clinical benefit?Alejo Rodriguez-Vida, Noan-Minh Chau, Simon Chowdhury
Cancer Treatment and Research|September 1, 2018
The Cancer Genome Atlas Project in Bladder CancerAlejo Rodriguez-Vida, Seth P Lerner, Joaquim Bellmunt
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2018
Immunotherapy Combinations and Sequences in Urothelial Cancer: Facts and HopesAlejo Rodriguez-Vida, Jose Luis Perez-Gracia, Joaquim Bellmunt
Expert Opinion on Drug Metabolism & Toxicology|September 16, 2022
Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug-drug interactionsDavid Conde-Estévez, Iván Henríquez, Jesús Muñoz-Rodríguez, et al.
Expert Review of Anticancer Therapy|October 31, 2014
Precision medicine for prostate cancerMyria Galazi, Alejo Rodriguez-Vida, Tony Ng, et al.
ESMO Open|August 2, 2017
New treatment options for metastatic renal cell carcinomaAlejo Rodriguez-Vida, Thomas E Hutson, Joaquim Bellmunt, et al.
Expert Review of Anticancer Therapy|November 19, 2013
The role of metastasectomy in renal cell carcinomaEleni Josephides, Alejo Rodriguez-Vida, Myria Galazi, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Expert Review of Anticancer Therapy|March 16, 2018
Avelumab for the treatment of urothelial cancerAlejo Rodriguez-Vida, Joaquim Bellmunt
JAMA Oncology|April 12, 2019
Treatment of Metastatic Urothelial Cancer in 2018Joaquim Bellmunt, Alejo Rodriguez-Vida
ESMO Open|November 16, 2016
Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinomaAlejo Rodriguez-Vida, Michiel Strijbos, Thomas Hutson
BJU International|February 18, 2014
Mammalian target of rapamycin (mTOR)-related non-infectious pneumonitis: a potential biomarker of clinical benefit?Alejo Rodriguez-Vida, Noan-Minh Chau, Simon Chowdhury
Cancer Treatment and Research|September 1, 2018
The Cancer Genome Atlas Project in Bladder CancerAlejo Rodriguez-Vida, Seth P Lerner, Joaquim Bellmunt
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2018
Immunotherapy Combinations and Sequences in Urothelial Cancer: Facts and HopesAlejo Rodriguez-Vida, Jose Luis Perez-Gracia, Joaquim Bellmunt
Expert Opinion on Drug Metabolism & Toxicology|September 16, 2022
Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug-drug interactionsDavid Conde-Estévez, Iván Henríquez, Jesús Muñoz-Rodríguez, et al.
Expert Review of Anticancer Therapy|October 31, 2014
Precision medicine for prostate cancerMyria Galazi, Alejo Rodriguez-Vida, Tony Ng, et al.
ESMO Open|August 2, 2017
New treatment options for metastatic renal cell carcinomaAlejo Rodriguez-Vida, Thomas E Hutson, Joaquim Bellmunt, et al.
Expert Review of Anticancer Therapy|November 19, 2013
The role of metastasectomy in renal cell carcinomaEleni Josephides, Alejo Rodriguez-Vida, Myria Galazi, et al.
Pageof 9